Template:DrugProjectFormSinglePageEUA: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
(6 intermediate revisions by the same user not shown) | |||
Line 69: | Line 69: | ||
</pre> | </pre> | ||
Edit the page to see the template text.</noinclude><includeonly>[[Page has default form::DrugProjectForm| ]][[Is of Type::Drug| ]]{{#if: {{{hasBlackBoxWarning|}}}|{{DrugPageSideBlackBox}}|{{ | Edit the page to see the template text.</noinclude><includeonly>[[Page has default form::DrugProjectForm| ]][[Is of Type::Drug| ]]{{#if: {{{hasBlackBoxWarning|}}}|{{DrugPageSideBlackBox}}|{{ | ||
DrugPageSideNoBlackBoxEUA}} }}<div style="width: 80%">__NOTOC____NOEDITSECTION__ | |||
{{CMG}}; {{#if: {{{authorTag|}}} | {{AE}} }} {{{authorTag|}}} | {{CMG}}; {{#if: {{{authorTag|}}} | {{AE}} }} {{{authorTag|}}} | ||
Line 87: | Line 87: | ||
{{#if: {{{fdaLIADAdult|}}} | | {{#if: {{{fdaLIADAdult|}}} | | ||
{{{fdaLIADAdult|}}} | | {{{fdaLIADAdult|}}} | | ||
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Adult)'' | There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Adult)''. | ||
}} | }} | ||
Line 105: | Line 105: | ||
{{#if: {{{fdaLIADPed|}}} | | {{#if: {{{fdaLIADPed|}}} | | ||
{{{fdaLIADPed|}}} | | {{{fdaLIADPed|}}} | | ||
There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Pediatric)'' | There is limited information regarding {{PAGENAME}} ''FDA-Labeled Indications and Dosage (Pediatric)''. | ||
}} | }} | ||
Line 121: | Line 121: | ||
{{#if: {{{contraindications|}}} | | {{#if: {{{contraindications|}}} | | ||
{{{contraindications|}}} | | {{{contraindications|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Contraindications'' | There is limited information regarding {{PAGENAME}} ''Contraindications''. | ||
}} | }} | ||
Line 130: | Line 130: | ||
{{#if: {{{warnings|}}}| | {{#if: {{{warnings|}}}| | ||
{{{warnings|}}} | | {{{warnings|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Warnings' | There is limited information regarding {{PAGENAME}} ''Warnings'. | ||
}} | }} | ||
Line 138: | Line 138: | ||
{{#if: {{{clinicalTrials|}}} | | {{#if: {{{clinicalTrials|}}} | | ||
{{{clinicalTrials|}}} | | {{{clinicalTrials|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Clinical Trials Experience'' | There is limited information regarding {{PAGENAME}} ''Clinical Trials Experience''. | ||
}} | }} | ||
Line 144: | Line 144: | ||
{{#if: {{{postmarketing|}}} | | {{#if: {{{postmarketing|}}} | | ||
{{{postmarketing|}}} | | {{{postmarketing|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Postmarketing Experience'' | There is limited information regarding {{PAGENAME}} ''Postmarketing Experience''. | ||
}} | }} | ||
Line 150: | Line 150: | ||
{{#if: {{{drugInteractions|}}} | | {{#if: {{{drugInteractions|}}} | | ||
{{{drugInteractions|}}} | | {{{drugInteractions|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Drug Interactions'' | There is limited information regarding {{PAGENAME}} ''Drug Interactions''. | ||
}} | }} | ||
Line 236: | Line 236: | ||
{{#if: {{{administration|}}} | | {{#if: {{{administration|}}} | | ||
{{{administration|}}} | | {{{administration|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Administration'' | There is limited information regarding {{PAGENAME}} ''Administration''. | ||
}} | }} | ||
Line 242: | Line 242: | ||
{{#if: {{{monitoring|}}} | | {{#if: {{{monitoring|}}} | | ||
{{{monitoring|}}} | | {{{monitoring|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Monitoring'' | There is limited information regarding {{PAGENAME}} ''Monitoring''. | ||
}} | }} | ||
Line 260: | Line 260: | ||
{{#if: {{{drugBox|}}} | | {{#if: {{{drugBox|}}} | | ||
{{{drugBox|}}} | | {{{drugBox|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Pharmacology'' | There is limited information regarding {{PAGENAME}} ''Pharmacology''. | ||
}} | }} | ||
Line 266: | Line 266: | ||
{{#if: {{{mechAction|}}} | | {{#if: {{{mechAction|}}} | | ||
{{{mechAction|}}} | | {{{mechAction|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Mechanism of Action'' | There is limited information regarding {{PAGENAME}} ''Mechanism of Action''. | ||
}} | }} | ||
Line 272: | Line 272: | ||
{{#if: {{{structure|}}} | | {{#if: {{{structure|}}} | | ||
{{{structure|}}} | | {{{structure|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Structure'' | There is limited information regarding {{PAGENAME}} ''Structure''. | ||
}} | }} | ||
Line 278: | Line 278: | ||
{{#if: {{{PD|}}} | | {{#if: {{{PD|}}} | | ||
{{{PD|}}} | | {{{PD|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Pharmacodynamics'' | There is limited information regarding {{PAGENAME}} ''Pharmacodynamics''. | ||
}} | }} | ||
Line 284: | Line 284: | ||
{{#if: {{{PK|}}} | | {{#if: {{{PK|}}} | | ||
{{{PK|}}} | | {{{PK|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Pharmacokinetics'' | There is limited information regarding {{PAGENAME}} ''Pharmacokinetics''. | ||
}} | }} | ||
Line 290: | Line 290: | ||
{{#if: {{{nonClinToxic|}}} | | {{#if: {{{nonClinToxic|}}} | | ||
{{{nonClinToxic|}}} | | {{{nonClinToxic|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Nonclinical Toxicology'' | There is limited information regarding {{PAGENAME}} ''Nonclinical Toxicology''. | ||
}} | }} | ||
Line 296: | Line 296: | ||
{{#if: {{{clinicalStudies|}}} | | {{#if: {{{clinicalStudies|}}} | | ||
{{{clinicalStudies|}}} | | {{{clinicalStudies|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Clinical Studies'' | There is limited information regarding {{PAGENAME}} ''Clinical Studies''. | ||
}} | }} | ||
Line 302: | Line 302: | ||
{{#if: {{{howSupplied|}}} | | {{#if: {{{howSupplied|}}} | | ||
{{{howSupplied|}}} | | {{{howSupplied|}}} | | ||
There is limited information regarding {{PAGENAME}} ''How Supplied'' | There is limited information regarding {{PAGENAME}} ''How Supplied''. | ||
}} | }} | ||
<!--- | |||
===Storage=== | ===Storage=== | ||
{{#if: {{{storage|}}} | | {{#if: {{{storage|}}} | | ||
{{{storage|}}} | | {{{storage|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Storage'' | There is limited information regarding {{PAGENAME}} ''Storage''. | ||
}} | }} | ||
==Images== | ==Images== | ||
===Drug Images=== | ===Drug Images=== | ||
Line 340: | Line 340: | ||
|sort=Label Page | |sort=Label Page | ||
}} | }} | ||
---> | |||
==Patient Counseling Information== | ==Patient Counseling Information== | ||
{{#if: {{{fdaPatientInfo|}}} | | {{#if: {{{fdaPatientInfo|}}} | | ||
{{{fdaPatientInfo|}}} | | {{{fdaPatientInfo|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Patient Counseling Information'' | There is limited information regarding {{PAGENAME}} ''Patient Counseling Information''. | ||
}} | }} | ||
Line 355: | Line 356: | ||
{{#if: {{{brandNames|}}} | | {{#if: {{{brandNames|}}} | | ||
{{{brandNames|}}} | | {{{brandNames|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Brand Names'' | There is limited information regarding {{PAGENAME}} ''Brand Names''. | ||
}} | }} | ||
Line 361: | Line 362: | ||
{{#if: {{{lookAlike|}}} | | {{#if: {{{lookAlike|}}} | | ||
{{{lookAlike|}}} | | {{{lookAlike|}}} | | ||
There is limited information regarding {{PAGENAME}} ''Look-Alike Drug Names'' | There is limited information regarding {{PAGENAME}} ''Look-Alike Drug Names''. | ||
}} | }} | ||
==[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm Drug Shortage Status]== | ==[http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm Drug Shortage Status]== | ||
{{{drugShortage|}}} | {{{drugShortage|}}} | ||
<!--- | |||
==Price== | ==Price== | ||
{{#Widget:DrugPrice|drugName={{{price}}} }} | {{#Widget:DrugPrice|drugName={{{price}}} }} | ||
---> | |||
==References== | ==References== | ||
The contents | The contents are provided by the [https://www.fda.gov/ U.S. Food and Drug Administration]. | ||
{{reflist|2}} | {{reflist|2}} | ||
</div> | </div> | ||
</includeonly> | </includeonly> |
Latest revision as of 19:34, 4 July 2020
This is the "Drug Project Form" template. It should be called in the following format:
{{DrugProjectForm |authorTag= |genericName= |drugClass= |indication= |indicationType= |commonAdverseReactions= |hasBlackBoxWarning= |blackBoxWarningTitle= |blackBoxWarningBody= |fdaLIADAdult= |offLabelAdultGuideSupport= |offLabelAdultNoGuideSupport= |fdaLIADPed= |offLabelPedGuideSupport= |offLabelPedNoGuideSupport= |contraindications= |warnings= |adverseReactions= |clinicalTrials= |postmarketing= |drugInteractions= |FDAPregCat= |useInPregnancyFDA= |AUSPregCat= |useInPregnancyAUS= |useInLaborDelivery= |useInNursing= |useInPed= |useInGeri= |useInGender= |useInRace= |useInRenalImpair= |useInHepaticImpair= |useInReproPotential= |useInImmunocomp= |othersTitle= |useInOthers= |administration= |monitoring= |IVCompat= |overdose= |drugBox= |mechAction= |structure= |PD= |PK= |nonClinToxic= |clinicalStudies= |howSupplied= |NDC= |storage= |manBy= |distBy= |drugImages= |packLabel= |fdaPatientInfo= |nlmPatientInfo= |alcohol= |brandNames= |lookAlike= |drugShortage= |price= }}
Edit the page to see the template text.